中文

稳健医疗 Revenue Breakdown

Period 2026-06-30 ・ Reported 2026-08-25

稳健医疗 reported revenue of ¥5.49B for the period ended 2026-06-30, +3.6% year on year. Net income was ¥0.55B, a 9.9% net margin on a 49.0% gross margin. The largest revenue line is 消费品 at 52% of the total. Free cash flow for the period was ¥0.32B.

ItemAmountY/Y
Revenue¥5.49B+3.6%
Gross profit¥2.69B
Operating income¥0.67B
Net income¥0.55B+5.2%
Gross margin49.0%Net margin 9.9%
Revenue Q/Q+4.8%

Revenue Segments

SegmentRevenueShare
消费品¥2.84B51.8%
医用耗材¥2.64B48.2%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥2.80B51.0%
R&D¥0.19B3.5%
SG&A¥1.75B31.9%
Tax & other¥0.12B2.2%

Balance sheet & cash flow

ItemAmount
Total assets¥18.97B
Total liabilities¥6.48B
Shareholders' equity¥12.49B
Equity / assets65.8%
Operating cash flow¥0.45B
Capital expenditure¥0.13B
Free cash flow¥0.32B
Cash conversion (OCF / net income)57%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

爱克股份翔丰华惠云钛业品渥食品松原安全火星人铜牛信息山科智能熊猫乳品上海凯鑫广联航空中胤时尚

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies